Clinical trial

Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction

NCT02262078

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-10-01

PhasePHASE2

Study timeline

Study start (unknown)2014-10-01Date precision: month

Registry last updated2017-08-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Sodium Nitrite Inhalation SolutionDRUG

PlaceboOTHER

Sponsors & collaborators

Mayo Cliniclead sponsor

Aires Pharmaceuticals, Inc.collaborator

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02262078 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.